Thrax Management’s Workiva WK Stock Holding History

Thrax Management’s Portfolio WK Stock Details WK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-34,655	Closed	-$609K	–	132
2015 Q4	$609K	Buy	+34,655	New	+$599K	0.13%	68

Other funds holding WK

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Thrax Management's WK Position: Q1 2016 in Review

Thrax Management sold out of Workiva (WK) in Q1 2016, closing a stake of 34,655 shares — an estimated $609K sold.

Thrax Management first reported a position in WK in Q4 2015 and held it in 1 quarter. The position peaked at $609K in Q4 2015. 58 funds tracked by Wall St. Rank hold WK as of Q1 2016.

Thrax Management reported no remaining Workiva position as of Q1 2016 after selling out during the quarter.
Thrax Management sold 34,655 Workiva shares in Q1 2016, an estimated $609K.
Thrax Management first reported a position in Workiva in Q4 2015 and held it in 1 quarter.
Thrax Management's Workiva position peaked at $609K in Q4 2015.
58 funds tracked by Wall St. Rank held Workiva as of Q1 2016.

Based on Thrax Management's 13F filing for Q1 2016, filed 16 May 2016.